India Glycols Limited (BOM:500201)

India Glycols Financials Overview

Financials in millions INR. Fiscal year is April - March.

Revenue & Profits

Chart

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Revenue Revenue Growth	43,013	42,114	37,683	32,940	26,509	28,683
Revenue Growth	12.01%	11.76%	14.40%	24.26%	-7.58%	23.79%
Gross Profit Gross Profit Growth	15,356	14,895	13,052	11,036	10,302	9,055
Operating Income Operating Income Growth	5,199	5,080	4,382	3,189	2,345	1,872
Net Income Net Income Growth	3,163	2,928	2,309	1,730	1,251	3,399
Earnings Per Share EPS Growth	48.68	45.95	37.29	27.94	20.20	54.88
EPS Growth	23.64%	23.22%	33.49%	38.30%	-63.19%	158.23%

Revenue by Segment

Chart

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Potable Spirits Potable Spirits Growth	73,600	69,464	64,339	55,749	47,452	44,193
Ennature Biopharma Ennature Biopharma Growth	2,406	2,078	2,194	2,051	1,917	1,562
Bio-fuel Bio-fuel Growth	14,456	14,699	10,436	5,123	-	-
Bio-Based Specialities and Performance Chemicals (Excluding Bio-Fuel) Bio-Based Specialities and Performance Chemicals (Excluding Bio-Fuel) Growth	-	12,025	13,421	16,292	-	-
Total Total Growth	103,120	98,266	90,390	79,215	66,416	66,014

Cash & Debt

Chart

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Cash & Investments Cash & Investments Growth	318.66	318.66	68.37	269.57	19.74	70.47
Total Debt Total Debt Growth	16,906	16,906	18,915	13,482	11,123	10,466
Net Cash (Debt) Net Cash Growth	-16,587	-16,587	-18,847	-13,213	-11,103	-10,395
Net Cash Growth	-	-	-	-	-	-
Net Cash Per Share Net Cash Per Share Growth	-255.25	-260.35	-304.36	-213.37	-179.30	-167.87

Cash Flow & CapEx

Chart

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Operating Cash Flow Operating Cash Flow Growth	-	7,692	3,621	4,385	3,257	1,160
Capital Expenditures CapEx Growth	-	-8,235	-7,605	-5,529	-4,388	-3,799
Free Cash Flow Free Cash Flow Growth	-	-543.12	-3,984	-1,144	-1,131	-2,639
Free Cash Flow Growth	-	-	-	-	-	-

Margins

Chart

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Gross Margin	35.70%	35.37%	34.64%	33.50%	38.86%	31.57%
Operating Margin	12.09%	12.06%	11.63%	9.68%	8.85%	6.53%
Pretax Margin	9.52%	8.96%	7.76%	6.78%	6.22%	12.87%
Profit Margin	7.35%	6.95%	6.13%	5.25%	4.72%	11.85%
FCF Margin	-	-1.29%	-10.57%	-3.47%	-4.26%	-9.20%

Dividends

Chart

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Nov 9, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Dividend Per Share Dividend Per Share Growth	7.500	7.500	5.000	4.000	3.750	3.750
Dividend Per Share Growth	0%	50.00%	25.00%	6.67%	0%	25.00%
Dividend Yield	2.43%	0.88%	0.90%	1.06%	1.22%	0.74%

Valuation

Chart

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Nov 9, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
PE Ratio	6.33	19.44	14.88	13.54	15.19	9.23
PS Ratio	0.49	1.35	0.91	0.71	0.72	1.09

Data Source: S&P Global Market Intelligence Last updated: Aug 12, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Nov 6, 2026

Data Sources Report a data error